Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2025 08:17 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers

BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers
May 22, 2025 07:00 ET | Source: BioStem Technologies, Inc.

Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist

Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist
May 01, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting

BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
April 30, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
April 21, 2025 07:07 ET | Source: BioStem Technologies, Inc.

BioStem Technologies to Present at the Centri Capital Conference

BioStem Technologies to Present at the Centri Capital Conference
April 01, 2025 16:49 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
March 31, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Announces Notice of Allowance for Two U.S. Patent Applications

BioStem Announces Notice of Allowance for Two U.S. Patent Applications
February 24, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology
January 08, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®

BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology
January 02, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies CEO to Present at Biotech Showcase 2025

BioStem Technologies CEO to Present at Biotech Showcase 2025

Next Page keyboard_arrow_right